Short-term safety and efficacy of ripasudil as “add-on therapy” in glaucoma patients on maximum tolerable glaucoma medication
Ripasudil is effective and tolerable in POAG patients already on maximal medical therapy. It can be utilized as an extra tool that can postpone invasive procedures, especially in the short term.
Authors
- Anita Ambasta (ORCID: https://orcid.org/0000-0002-9491-000X)
- Vidya Bhushan Kumar
- Bhawesh C Saha
- Rashmi Kumari (ORCID: https://orcid.org/0000-0002-3255-9904)
Institutions
- Indira Gandhi Institute of Medical Sciences (IN)
- All India Institute of Medical Sciences, Deoghar (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Saudi Journal of Ophthalmology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.4103/sjopt.sjopt_201_24
- Citations
- 2
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.08